Related Experiment Video
Updated: May 29, 2025

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
Published on: January 7, 2019
Hypervirulent Klebsiella pneumoniae (hvKp): Overview, Epidemiology, and Laboratory Detection
Dania Al Ismail1, Edgar I Campos-Madueno1, Valentina Donà2
1Institute for Infectious Diseases (IFIK), University of Bern, Bern, Switzerland.
Abstract:
Klebsiella pneumoniae (Kp) is a Gram-negative pathogen responsible for both hospital- and community-acquired infections. Kp is classified into 2 distinct pathotypes: classical K. pneumoniae (cKp) and hypervirulent K. pneumoniae (hvKp). First described in Taiwan in 1986, hvKp are highly pathogenic and characterized by unique phenotypic and genotypic traits. The hypermucoviscous (hmv) phenotype, generally marked by overproduction of the capsule, is often associated with hvKp, although recent studies show that some cKp strains may also have this characteristic. Furthermore, hvKp can cause severe community-acquired infections in healthy people and have been associated with metastatic infections such as liver abscess, meningitis, and endophthalmitis. HvKp are increasingly being reported in hospital-acquired settings, complicating treatment strategies. In particular, while hvKp have historically been antibiotic-susceptible, multidrug-resistant (MDR) strains have emerged and pose a significant public health threat. The combination of high virulence and limited antibiotic options demands further research into virulence mechanisms and rapid identification methods. This review discusses the epidemiology of hvKp and their virulence factors, highlighting the importance of phenotypic and non-phenotypic tests, including next-generation molecular diagnostics, for the early detection of hvKp.
Insights
Hypervirulent Klebsiella pneumoniae (hvKp) causes severe infections and is increasingly resistant to antibiotics. Early detection through molecular diagnostics is crucial for effective treatment of this emerging public health threat.
Area of Science:
- Microbiology
- Infectious Diseases
- Pathogen Research
Background:
- Klebsiella pneumoniae (Kp) is a Gram-negative bacterium causing significant hospital and community infections.
- Kp exists as two pathotypes: classical (cKp) and hypervirulent (hvKp), with hvKp exhibiting higher pathogenicity and unique traits.
- hvKp strains are associated with severe community-acquired infections, metastatic infections, and are increasingly implicated in hospital-acquired infections.
Purpose of the Study:
- To review the epidemiology and virulence factors of hypervirulent Klebsiella pneumoniae (hvKp).
- To emphasize the importance of early detection methods for hvKp.
- To highlight the challenges posed by multidrug-resistant (MDR) hvKp strains.
Main Methods:
- Review of existing literature on hvKp epidemiology, virulence, and detection.
- Discussion of phenotypic and non-phenotypic diagnostic approaches.
- Exploration of next-generation molecular diagnostics for rapid identification.
Main Results:
- hvKp strains are characterized by unique phenotypic (e.g., hypermucoviscous) and genotypic traits.
- Emergence of multidrug-resistant (MDR) hvKp strains presents a significant public health challenge.
- Traditional antibiotic susceptibility is changing, necessitating updated treatment strategies.
Conclusions:
- Early and accurate detection of hvKp is critical due to their high virulence and increasing antibiotic resistance.
- Next-generation molecular diagnostics offer promising avenues for rapid hvKp identification.
- Further research into hvKp virulence mechanisms and diagnostic tools is essential.
More Related Videos
06:11Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Steps in Outbreak Investigation
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: